TABLE 1.
Oligodeoxynucleotides and analogsa
| Name | Sequence | Length (bp) |
|---|---|---|
| ODN1 | TTTTACTGCTGCGTAACATCGTTGCTG | 20 |
| ODN2 | GTAACATCGTTGCTG | 15 |
| ODN3 | GCGTAACATCGTTGC | 15 |
| ODN4 | CTGCTGCGTAACATC | 15 |
| ODNS | GATGTTACGCAGCAG | 15 |
| ODNAP | AGCGGTAAGGCATCT | 15 |
| CPPBD4 | (RXR)4XB-Cys-SMCC-C6 amino-C+TGCT+GCGT+AACA+TC | 15 |
| CPPBDAP | (RXR)4XB-Cys-SMCC-C6 amino-A+GCGG+TAAG+GCAT+CT | 15 |
a
ODNs are oligodeoxynucleotides; CPPBDs are permeabilizing peptide-conjugated 2′,4′-bridged nucleic acid residue and deoxynucleotide hybrid compounds. R, arginine; X, 6-aminohexanoic acid; B, β-alanine, +N, BNANC; SMCC, sulfosuccinimidyl-trans-4-(N-maleimidomethyl)cyclohexane-1-carboxylate.